Volume 6, Emitir 4 (2009)
Artigo de Revisão
Lifestyle management: preventing Type 2 diabetes and cardiovascular complications
Rebecca S Stiegler, Paul Z Zimmet, Adrian J Cameron and Jonathan E Shaw
Artigo de Pesquisa
Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life
Jose Dinis, Tami Wisniewski, Antonio Moreira, Joao Raposo, Larry Ma & Thomas A Burke
Artigo de Revisão
Glycemic control and cardiovascular disease in a high-risk chronic kidney disease population
Rachandeep Singh, Ravi Nistala, Samy I McFarlane and Adam Whaley-Connell
Editorial
Does normalization of blood glucose reduce the rate of cardiovascular events?
Sabreena Basu
Artigo de Revisão
Novel strategies and future landmarks in the treatment of irritable bowel syndrome
Richard Roka, Krisztina Gecse and Tibor Wittmann
Destaques da Pesquisa
Fenofibrate effects on cardiovascular outcomes in patients with diabetes and metabolic syndrome
Brian K Irons
Avaliação de Medicamentos
Pemetrexed in the treatment of malignant pleural mesothelioma
Michael D Peake
Avaliação de Medicamentos
Ofatumumab for the treatment of chronic lymphocytic leukemia
Tadeusz Robak
Artigo de Revisão
Treatment of hypertension in the diabetic patient
Amgad N Makaryus and Samy I McFarlane
Relatório especial
Pharmacogenomics and the prevention of vascular complications in diabetes mellitus
Dan Farbstein and Andrew P Levy
Avaliação de Medicamentos
Lapatinib in the management of breast cancer
Peter S Hall, Jaishree Bhosle and David A Cameron
Relato de caso
Efficacy of clobazam monotherapy in three cases of symptomatic localization-related epilepsy in children
Toshiyuki Iwasaki, Yutaka Nonoda, Kenji Takei, Nozomi Hosoda and Masahiro Ishii
Prefácio
Diabetes and cardiovascular disease: time for individualized risk reduction
Samy I McFarlane and James R Sowers
Avaliação de Medicamentos
Colesevelam hydrochloride: a bile acid sequestrant for glycemic control and treatment of dyslipidemia in Type 2 diabetes mellitus
Prasanth N Surampudi, Prathima Nagireddy and Vivian A Fonseca
Editorial
Will computational simulation in congenital heart disease ever make it out of the engineering lab and into the clinic?
Alison L Marsden and Jeffrey A Feinstein
Artigo de Revisão
Hyperglycemia, dyslipidemia and hypertension in older people with diabetes: the benefits of cardiovascular risk reduction
Siobhan HM Brown and Ahmed H Abdelhafiz
